We used a prospective cohort study of 2,910 patients with invasive breast cancer to examine whether plasma CRP levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer. This evidence concerns the gene CRP and breast carcinoma.